Monoclonal Gammopathy of Renal Significance (MGRS) Diagnosis and Classification
Authored by Sourabh Sharma, published on 2026-11-18 17:53:44.0
Unexplained Proteinuria, Haematuria, AKI/CKD, or eGFR Decline With Suspected Monoclonal Gammopathy
Obtain SPEP/SIFE, UPEP/UIFE, Serum FLC, Proteinuria Quantification, Urine Microscopy, Renal Function, and Relevant Biochemistry
Do Serum or Urine Studies Detect a Monoclonal Protein?
Does Renal Phenotype Warrant Biopsy, and Is Biopsy Safe?
Obtain Kidney Biopsy; Ensure LM, IF, EM, and Congo Red
Does Integrated Pathology Identify an MGRS-Compatible Lesion?
Classify Lesion by Deposit Composition and Ultrastructure
Organized Deposits: AL/AH/AHL Amyloidosis, Immunotactoid, Type I Cryoglobulinaemic, or Monotypic Fibrillary GN
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Nonorganized Deposits: MIDD, PGNMID, or Monoclonal Membranous Patterns
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Tubular or Crystalline Lesions: Cast Nephropathy, LCPT, or Crystal-Storing Disease
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Indirect or Sparse-Deposit Lesions: C3 Glomerulopathy or TMA
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Do Reference-Centre Proteomics or Ancillary IF Establish Deposit Identity?
Classify Lesion by Deposit Composition and Ultrastructure
Organized Deposits: AL/AH/AHL Amyloidosis, Immunotactoid, Type I Cryoglobulinaemic, or Monotypic Fibrillary GN
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Nonorganized Deposits: MIDD, PGNMID, or Monoclonal Membranous Patterns
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Tubular or Crystalline Lesions: Cast Nephropathy, LCPT, or Crystal-Storing Disease
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Indirect or Sparse-Deposit Lesions: C3 Glomerulopathy or TMA
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Classify as Indeterminate; Reassess or Repeat Biopsy if Disease Evolves
Treat Alternative Biopsy Diagnosis; Classify Gammopathy Independently
Do Not Diagnose MGRS; Monitor and Reassess Biopsy Need
Apply CKD- and Assay-Adjusted FLC Interpretation; Proceed if Suspicion Persists
Does Renal Phenotype Warrant Biopsy, and Is Biopsy Safe?
Obtain Kidney Biopsy; Ensure LM, IF, EM, and Congo Red
Does Integrated Pathology Identify an MGRS-Compatible Lesion?
Classify Lesion by Deposit Composition and Ultrastructure
Organized Deposits: AL/AH/AHL Amyloidosis, Immunotactoid, Type I Cryoglobulinaemic, or Monotypic Fibrillary GN
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Nonorganized Deposits: MIDD, PGNMID, or Monoclonal Membranous Patterns
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Tubular or Crystalline Lesions: Cast Nephropathy, LCPT, or Crystal-Storing Disease
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Indirect or Sparse-Deposit Lesions: C3 Glomerulopathy or TMA
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Do Reference-Centre Proteomics or Ancillary IF Establish Deposit Identity?
Classify Lesion by Deposit Composition and Ultrastructure
Organized Deposits: AL/AH/AHL Amyloidosis, Immunotactoid, Type I Cryoglobulinaemic, or Monotypic Fibrillary GN
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Nonorganized Deposits: MIDD, PGNMID, or Monoclonal Membranous Patterns
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Tubular or Crystalline Lesions: Cast Nephropathy, LCPT, or Crystal-Storing Disease
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Indirect or Sparse-Deposit Lesions: C3 Glomerulopathy or TMA
Perform Marrow Aspirate/Biopsy, Flow, FISH/Cytogenetics, and Clone-Directed Imaging
Are Myeloma, WM, CLL, Lymphoma, or Other Overt Malignancy Criteria Met?
Manage Through the Relevant Overt Haematological Malignancy Pathway
Assess Three-Way Concordance: Clone or Protein, Renal Lesion, and Causality
Confirm and Classify MGRS by Renal Lesion and Clone
Diagnose MGRS-Compatible Lesion With Clone Not Detected
Classify Coincidental MGUS With Unrelated Kidney Disease
Repeat Targeted Monoclonal and Pathology Studies With Expert Review
Classify as Indeterminate; Reassess or Repeat Biopsy if Disease Evolves
Treat Alternative Biopsy Diagnosis; Classify Gammopathy Independently
Do Not Diagnose MGRS; Monitor and Reassess Biopsy Need
Do Not Diagnose MGRS From CKD Plus M-Protein Alone
Negative Studies Do Not Exclude MGRS; Escalate to Reference-Centre Testing
tos
privacy